Sun Pharma has received a final approval to market Oxycodone Hydrochloride tablet in the strengths of 5 mg, 15 mg and 30 mg from the United States Food and Drug Administration (USFDA).

OxyContin is a controlled-release form of the narcotic painkiller oxycodone. It is prescribed for moderate to severe pain when continuous, around-the-clock relief is needed for an extended period of time.

The company operates in select therapeutic segments like psychiatry, neurology, cardiology and gastroenterology.

Shares of the company closed up Rs 24.85, or 2.05%, at Rs 1,236.25. The total volume of shares traded at the BSE was 16,873 (Thursday).